DOCSLIB.ORG

Sigma Biochemical Condensed Phase

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Sigma Biochemical Condensed Phase Sigma Biochemical Condensed Phase Library Listing – 10,411 spectra This library provides a comprehensive spectral collection of the most common chemicals found in the Sigma Biochemicals and Reagents catalog. It includes an extensive combination of spectra of interest to the biochemical field. The Sigma Biochemical Condensed Phase Library contains 10,411 spectra acquired by Sigma-Aldrich Co. which were examined and processed at Thermo Fisher Scientific. These spectra represent a wide range of chemical classes of particular interest to those engaged in biochemical research or QC. The spectra include compound name, molecular formula, CAS (Chemical Abstract Service) registry number, and Sigma catalog number. Sigma Biochemical Condensed Phase Index Compound Name Index Compound Name 8951 (+)-1,2-O-Isopropylidene-sn-glycerol 4674 (+/-)-Epinephrine methyl ether .HCl 7703 (+)-10-Camphorsulfonic acid 8718 (+/-)-Homocitric acid lactone 10051 (+)-2,2,2-Trifluoro-1-(9-anthryl)ethanol 4739 (+/-)-Isoproterenol .HCl 8016 (+)-2,3-Dibenzoyl-D-tartaric acid 4738 (+/-)-Isoproterenol, hemisulfate salt 8948 (+)-2,3-O-Isopropylidene-2,3- 5031 (+/-)-Methadone .HCl dihydroxy-1,4-bis- 9267 (+/-)-Methylsuccinic acid (diphenylphosphino)but 9297 (+/-)-Miconazole, nitrate salt 6164 (+)-2-Octanol 9361 (+/-)-Nipecotic acid 9110 (+)-6-Methoxy-a-methyl-2- 9618 (+/-)-Phenylpropanolamine .HCl naphthaleneacetic acid 4923 (+/-)-Sulfinpyrazone 7271 (+)-Amethopterin 10404 (+/-)-Taxifolin 4368 (+)-Bicuculline 4469 (+/-)-Tetrahydropapaveroline .HBr 7697 (+)-Camphor 4992 (+/-)-Verapamil, .HCl 7729 (+)-Catechin .H2O 9145 (+/-)-a-(Methylaminomethyl)benzyl 7868 (+)-Citramalic acid, Na salt alcohol 4401 (+)-Ephedrine .HCl 9146 (+/-)-a-(Methylaminomethyl)benzyl 8932 (+)-Isomenthol alcohol, benzoate salt 4742 (+)-Isoproterenol (+)-bitartrate 4777 (+/-)Metoprolol (+)tartrate 9009 (+)-Longifolene 4405 (-) Ephedrine nitrate 5032 (+)-Methamphetamine .HCl 4987 (-) Usnic acid 8022 (+)-N,N'-Dibenzyl-L-tartramide 8400 (-)-1,4-Dithio-L-threitol 9350 (+)-Neomenthol 10052 (-)-2,2,2-Trifluoro-1-(9-anthryl)ethanol 9476 (+)-Noe-lactol dimer 8403 (-)-2,3-Di-p-toluoyl-L-tartaric acid 941 (+)-Octopinic acid 8017 (-)-2,3-Dibenzoyl-L-tartaric acid 9619 (+)-Phenylpropanolamine .HCl 8947 (-)-2,3-O-Isopropylidene-2,3-dihydroxy- 4395 (+)-Psi-ephedrine 1,4-bis-(diphenylphosphino)but 4397 (+)-Psi-ephedrine .HCl 8952 (-)-2,3-O-Isopropylidene-sn-glycerol 4396 (+)-Psi-ephedrine hemisulfate 6165 (-)-2-Octanol 9862 (+)-Tartaric acid dibutyl ester 4391 (-)-3,4-Dihydroxy-norephedrine 9863 (+)-Tartaric acid diethyl ester 474 (-)-Allo-cystathionine 9865 (+)-Tartaric acid dimethyl ester 7272 (-)-Amethopterin 4988 (+)-Usnic acid 4540 (-)-Arterenol 9132 (+)-a-Methoxy-a- 4542 (-)-Arterenol .HCl (trifluoromethyl)phenylacetic acid 4541 (-)-Arterenol bitartrate 9670 (+)-a-Pinene 4369 (-)-Bicuculline methobromide 7650 (+)-p-Bromotetramisole oxalate 7575 (-)-Borneol 4413 (+)Glaucine 7576 (-)-Bornyl acetate 6146 (+/-) Linalool 7867 (-)-Citramalic acid, Na salt 8086 (+/-)-1,2:3,4-Diepoxybutane 4386 (-)-Cotinine 8034 (+/-)-2,3-Dibromopropionitrile 4404 (-)-Ephedrine .HCl 8480 (+/-)-2-Ethylhexylamine 4402 (-)-Ephedrine anhydrous 6163 (+/-)-2-Octanol 4403 (-)-Ephedrine hemi-sulfate 6162 (+/-)-2-Octanol 8418 (-)-Epicatechin 4887 (+/-)-3-Quinuclidinol 4672 (-)-Epinephrine 9780 (+/-)-3-Quinuclidinol benzoate 4673 (-)-Epinephrine (+)-bitartrate 7273 (+/-)-Amethopterin 4740 (-)-Isoproterenol 4538 (+/-)-Arterenol 4741 (-)-Isoproterenol (+)-bitartrate 4539 (+/-)-Arterenol .HCl 9063 (-)-Menthyl chloride 7493 (+/-)-Benzoin 9064 (-)-Menthyloxyacetic acid 7698 (+/-)-Camphor 8023 (-)-N,N'-Dibenzyl-D-tartramide 7730 (+/-)-Catechin; 2-(3,4- 9477 (-)-Noe-lactol dimer Dihydroxyphenyl)-3,4-dihydro-2H-1- 4440 (-)-Norpseudoephedrine .HCl benzopyran-3 4398 (-)-Psi ephedrine 7866 (+/-)-Citramalic acid, Na salt 4399 (-)-Psi ephedrine .HCl 4383 (+/-)-Coniine 4446 (-)-Quinic acid 473 (+/-)-Cystathionine 4459 (-)-Scopolamine .HBr 4400 (+/-)-Ephedrine .HCl 4458 (-)-Scopolamine N-butylbromide 2629 (+/-)-Epi-inosose-2 4457 (-)-Scopolamine aminoxide .HBr 4671 (+/-)-Epinephrine 4460 (-)-Scopolamine methyl bromide (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 1 of 106 Sigma Biochemical Condensed Phase Index Compound Name Index Compound Name 4461 (-)-Scopolamine methyl nitrate 5576 (E)-Vaccenic acid methyl ester 9816 (-)-Shikimic acid 2373 (E)-Vaccenoyl coenzyme A 4463 (-)-Sparteine 4573 (E)-b-Carotene type I 9820 (-)-Sparteine, sulfate salt 8151 (E)-d3-Dihydromuconic acid 9864 (-)-Tartaric acid diethyl ester 8373 (E)-p,p'-Diphenylstilbene 9133 (-)-a-Methoxy-a- 9307 (E,E)-Muconic acid (trifluoromethyl)phenylacetic acid 9113 (Methoxymethyl)triphenylphosphonium 7651 (-)-p-Bromotetramisole oxalate chloride 4393 (-)Eburnamonine 7555 (R)-(+)-1,1'-Bi-2-naphthol 9062 (-)Menthol 5177 (R)-(+)-2-Chloropropionic acid methyl 7702 (1R)-(-)-Camphoroquinone ester 4435 (1R,2S)-(-)-N-Methylephedrine 8293 (R)-(+)-N,N-Dimethyl-1- 10024 (2,2,2-Trichloro-1- phenethylamine hydroxyethyl)phosphonic acid dimethyl 9338 (R)-(+)-a-(1-Naphthyl)ethylamine ester 7557 (R)-(-)-1,1'-Binaphthyl-2,2'-diyl 7617 (2-Bromoethyl)trimethylammonium hydrogen phosphate bromide 6113 (R)-(-)-1,3-Butanediol 6174 (2R,4R)-(-)-Pentanediol 6154 (R)-(-)-2-Methyl-2,4-pentanediol 8237 (2S,3R)-(+)-4-Dimethylamino-1,2- 8806 (R)-(-)-3-Hydroxy-2-methylpropionic diphenyl-3-methyl-2-butanol acid methyl ester 7267 (2S,3S)-(+)-2-Allyl-3-hydroxy-2- 9201 (R)-(-)-Methyl 3-hydroxybutyrate methylcyclopentanone 9158 (R,R)-(+)-N,N'-Bis(a- 6175 (2S,4S)-(+)-Petanediol methylbenzyl)sulfamide 7726 (3-Carboxypropyl)trimethylammonium 6116 (R,R)-(-)-2,3-Butanediol chloride 7558 (S)-(+)-1,1'-Binaphthyl-2,2'-diyl 7719 (4-Carboxybutyl)triphenylphosphonium hydrogen phosphate bromide 6181 (S)-(+)-1,2-Propandiol 7760 (4R,5R)-(+)-2-Chloro-4,5-dimethyl- 6114 (S)-(+)-1,3-Butanediol 1,3,2-dioxaphosphole 9111 (S)-(+)-2-(Methoxymethyl)pyrrolidine 7320 (4S,5S)-(+)-5-Amino-2,2-dimethyl-4- 9161 (S)-(+)-2-Methylbutyric acid phenyl-1,3-dioxane 8807 (S)-(+)-3-Hydroxy-2-methylpropionic 7363 (Aminooxy)acetic acid .1/2 HCl acid methyl ester 10049 (Bis(trifluoroacetoxy)iodo)benzene 9202 (S)-(+)-Methyl 3-hydroxybutyrate 7712 (Carbomethoxymethyl)triphenylphospho 7556 (S)-(-)-1,1'-Bi-2-naphthol nium bromide 9112 (S)-(-)-2-(Methoxymethyl)-1- 7723 (Carboxymethyl)trimethylammonium pyrrolidinecarboxaldehyde chloride hydrazide 6151 (S)-(-)-2-Methyl-1-butanol 8377 (E)-1,4-Diphthalimido-2-methyl-2- 9166 (S)-(-)-Methyl 2-chloropropionate butene 8294 (S)-(-)-N,N-Dimethyl-1-phenethylamine 5543 (E)-11-Tetradecenyl acetate 9712 (S)-(-)-Propylene oxide 8052 (E)-2,4-Dichlorocinnamic acid 9339 (S)-(-)-a-(1-Naphthyl)ethylamine 5197 (E)-2-Dodecenedioic acid 9159 (S,S)-(-)-N,N'-Bis(a- 8709 (E)-2-Hexenal methylbenzyl)sulfamide 9504 (E)-2-Octene 5218 (Z)-11-Eicosenoic anhydride 9130 (E)-4-Methoxystilbene 8691 (Z)-11-Hexadecenal 9505 (E)-4-Octene 8693 (Z)-11-Hexadecenol 7957 (E)-5-Decenol 5259 (Z)-11-Hexadecenyl acetate 5178 (E)-5-Decenyl acetate 9896 (Z)-11-Tetradecenol 5194 (E)-7,(Z)-9-Dodecadienyl acetate 5542 (Z)-11-Tetradecenyl acetate 6127 (E)-8,(E)-10-Dodecadienol 9496 (Z)-13-Octadecenal 5195 (E)-8,(E)-10-Dodecadienyl acetate 9196 (Z)-14-Methyl-8-hexadecenal 5083 (E)-Aconitic acid 5260 (Z)-3-Hexenyl acetate 4530 (E)-Anethole 6160 (Z)-3-Nonen-1-ol 7859 (E)-Cinnamic acid 5429 (Z)-3-Nonenyl acetate 7861 (E)-Cinnamoyl chloride 5179 (Z)-5-Decenyl acetate 9830 (E)-Stilbene 5256 (Z)-7,(E)-11-Hexadecadienyl acetate 9831 (E)-Stilbene oxide 5255 (Z)-7,(Z)-11-Hexadecadienyl acetate 4929 (E)-Tamoxifen citrate 6128 (Z)-7-Dodecen-1-ol 5574 (E)-Vaccenic acid 5198 (Z)-7-Dodecenyl acetate (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 2 of 106 Sigma Biochemical Condensed Phase Index Compound Name Index Compound Name 9893 (Z)-7-Tetradecenal 2847 1,2,3,5-Tetra-O-benzoyl-a-D- 6187 (Z)-7-Tetradecenol xylofuranose 5541 (Z)-7-Tetradecenyl acetate 7475 1,2,3-Benzenetricarboxylic acid .2H2O 5199 (Z)-8-Dodecenyl acetate 6138 1,2,3-Heptanetriol 5538 (Z)-9,(E)-11-Tetradecadienyl acetate 7476 1,2,4-Benzenetricarboxylic acid 5539 (Z)-9,(E)-12-Tetradecadienyl acetate 10008 1,2,4-Triazole 8668 (Z)-9-Heneicosene 10078 1,2,4-Trimethoxybenzene 8690 (Z)-9-Hexadecenal 10065 1,2,6-Trihydroxyhexane 5258 (Z)-9-Hexadecenyl acetate 7471 1,2-Benzanthracene 9895 (Z)-9-Tetradecenol 7365 1,2-Bis(2-aminophenoxy)ethane- 6188 (Z)-9-Tetradecenol N,N,N',N'-tetraacetic acid, tetrapotass 10032 (Z)-9-Tricosene 7766 1,2-Bis(2-chloroethoxy)ethane 5082 (Z)-Aconitic acid 5640 1,2-Di-O-hexadecyl-3-palamitoyl-rac- 7246 (Z)-Aconitic anhydride glycerol 9829 (Z)-Stilbene 5641 1,2-Di-O-hexadecyl-rac-glycerol 5573 (Z)-Vaccenic acid 7967 1,2-Diacetylbenzene 5575 (Z)-Vaccenic acid methyl ester 7979 1,2-Diaminocyclohexane-N,N,N',N'- 5577 (Z)-Vaccenoyl chloride tetraacetic acid, trans- 2372 (Z)-Vaccenoyl coenzyme A 7990 1,2-Diaminopropane-N,N,N',N'- 5578 (Z)-Vaccenyl acetate tetraacetic acid 6191 (Z)-Vaccenyl alcohol 8000 1,2-Dianilinoethane 7715 1,1'-Carbonyldiimidazole 8028 1,2-Dibromoethane 8014 1,1'-Dibenzoylferrocene 8055 1,2-Dichloroethane 8103 1,1'-Diethyl-2,2'-cyanine iodide 8162 1,2-Dihydroxyethylene-bis-acrylamide 9956 1,1'-Thiocarbonyldiimidazole 5645 1,2-Dilauroyl-rac-glycerol 10091 1,1'-Trimethylene-bis-(4- 8279 1,2-Dimethylimidazole formylpyridinium bromide) dioxime 5649 1,2-Dimyristoyl-rac-glycerol 6140 1,1,1,3,3,3-Hexafluoro-2-propanol 5652 1,2-Dioleoyl-rac-glycerol 10025 1,1,1-Trichloro-2-methyl-2-propanol 5654 1,2-Dipalmitoyl-3-O-benzyl-rac- 1/2 .H2O glycerol 8828 1,1,2,2-Tetrakis-(p-
Load more

Recommended publications
  • Pseudo-Cholinesterase in Rat Erythrocytes Basis of Its Substrate Ratio, It Is Possible That It May Be a Butyro-Cholinesterase
    No. 4535 September 29, 1956 NATURE 697 Pseudo-cholinesterase in Rat Erythrocytes basis of its substrate ratio, it is possible that it may be a butyro-cholinesterase. .ALTHOUGH there are many references in the literature to the existence of different types of cholin­ D.R. DAVIES esterase in mammalian sera1, it is generally believed J. P. RUTLAND 2 that human red cells contain only one type • Further­ more, we can find no evidence in the literature for Chemical Defence Experimental Establishment the existence of a pseudo-cholinesterase in any (Ministry of Supply), mammalian erythrocytes, although many workers Porton, Salisbury. have stated that benzoylcholine is hydrolysed by May 3. red cells. Since, however, the rate of hydrolysis is 1 Mundell, D. B., Nature, 153, 557 (1944). Ellis, S., Sanders, S., and slow, this breakdown of a substrate formerly presumed Bodansky, 0., J. Pharmacol., 91, 225 (1947). Levine M G and Suran, A. A., Enzymologia, 15, 17 (1951). ' · ., to be specific for pseudo-cholinesterase has been 'Mendell, B., Mundell, D. B., and Rudney, H., Biochem. J. 37 473 attributed to true cholinesterase. Indeed, Adams3 (1943). ' ' has shown that purified true cholinesterase does • Adams, D. H., Bwchim. Biophys. Acta, ~. 1 (1949). hydrolyse benzoylcholine, at a rate which would • Fraser, P. ~-, ti:,esis, University of Birmingham (1951), and private commumcat10n (1956). account for such observations. In spite of this, • Aldridge, W. N., Biochem. J., 53, 62 (1953). Austin, L., and Berry some results obtained by Fraser with benzoylcholine• W. K., Bwchem. J., 54, 695 (1953). ' imply the existence of more than one type of cholin­ 'Bayliss, B.
    [Show full text]
  • Aldrich FT-IR Collection Edition I Library
    Aldrich FT-IR Collection Edition I Library Library Listing – 10,505 spectra This library is the original FT-IR spectral collection from Aldrich. It includes a wide variety of pure chemical compounds found in the Aldrich Handbook of Fine Chemicals. The Aldrich Collection of FT-IR Spectra Edition I library contains spectra of 10,505 pure compounds and is a subset of the Aldrich Collection of FT-IR Spectra Edition II library. All spectra were acquired by Sigma-Aldrich Co. and were processed by Thermo Fisher Scientific. Eight smaller Aldrich Material Specific Sub-Libraries are also available. Aldrich FT-IR Collection Edition I Index Compound Name Index Compound Name 3515 ((1R)-(ENDO,ANTI))-(+)-3- 928 (+)-LIMONENE OXIDE, 97%, BROMOCAMPHOR-8- SULFONIC MIXTURE OF CIS AND TRANS ACID, AMMONIUM SALT 209 (+)-LONGIFOLENE, 98+% 1708 ((1R)-ENDO)-(+)-3- 2283 (+)-MURAMIC ACID HYDRATE, BROMOCAMPHOR, 98% 98% 3516 ((1S)-(ENDO,ANTI))-(-)-3- 2966 (+)-N,N'- BROMOCAMPHOR-8- SULFONIC DIALLYLTARTARDIAMIDE, 99+% ACID, AMMONIUM SALT 2976 (+)-N-ACETYLMURAMIC ACID, 644 ((1S)-ENDO)-(-)-BORNEOL, 99% 97% 9587 (+)-11ALPHA-HYDROXY-17ALPHA- 965 (+)-NOE-LACTOL DIMER, 99+% METHYLTESTOSTERONE 5127 (+)-P-BROMOTETRAMISOLE 9590 (+)-11ALPHA- OXALATE, 99% HYDROXYPROGESTERONE, 95% 661 (+)-P-MENTH-1-EN-9-OL, 97%, 9588 (+)-17-METHYLTESTOSTERONE, MIXTURE OF ISOMERS 99% 730 (+)-PERSEITOL 8681 (+)-2'-DEOXYURIDINE, 99+% 7913 (+)-PILOCARPINE 7591 (+)-2,3-O-ISOPROPYLIDENE-2,3- HYDROCHLORIDE, 99% DIHYDROXY- 1,4- 5844 (+)-RUTIN HYDRATE, 95% BIS(DIPHENYLPHOSPHINO)BUT 9571 (+)-STIGMASTANOL
    [Show full text]
  • 8–21–09 Vol. 74 No. 161 Friday Aug. 21, 2009 Pages 42169–42572
    8–21–09 Friday Vol. 74 No. 161 Aug. 21, 2009 Pages 42169–42572 VerDate Nov 24 2008 21:37 Aug 20, 2009 Jkt 217001 PO 00000 Frm 00001 Fmt 4710 Sfmt 4710 E:\FR\FM\21AUWS.LOC 21AUWS srobinson on DSKHWCL6B1PROD with MISCELLANEOUS II Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 The FEDERAL REGISTER (ISSN 0097–6326) is published daily, SUBSCRIPTIONS AND COPIES Monday through Friday, except official holidays, by the Office of the Federal Register, National Archives and Records PUBLIC Administration, Washington, DC 20408, under the Federal Register Subscriptions: Act (44 U.S.C. Ch. 15) and the regulations of the Administrative Paper or fiche 202–512–1800 Committee of the Federal Register (1 CFR Ch. I). The Assistance with public subscriptions 202–512–1806 Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402 is the exclusive distributor of the official General online information 202–512–1530; 1–888–293–6498 edition. Periodicals postage is paid at Washington, DC. Single copies/back copies: The FEDERAL REGISTER provides a uniform system for making Paper or fiche 202–512–1800 available to the public regulations and legal notices issued by Assistance with public single copies 1–866–512–1800 Federal agencies. These include Presidential proclamations and (Toll-Free) Executive Orders, Federal agency documents having general FEDERAL AGENCIES applicability and legal effect, documents required to be published by act of Congress, and other Federal agency documents of public Subscriptions: interest. Paper or fiche 202–741–6005 Documents are on file for public inspection in the Office of the Assistance with Federal agency subscriptions 202–741–6005 Federal Register the day before they are published, unless the issuing agency requests earlier filing.
    [Show full text]
  • Analytical Performance of an Immunoassay to Measure Proenkephalin ⁎ Leslie J
    Clinical Biochemistry xxx (xxxx) xxx–xxx Contents lists available at ScienceDirect Clinical Biochemistry journal homepage: www.elsevier.com/locate/clinbiochem Analytical performance of an immunoassay to measure proenkephalin ⁎ Leslie J. Donatoa, ,Jeffrey W. Meeusena, John C. Lieskea, Deborah Bergmannc, Andrea Sparwaßerc, Allan S. Jaffea,b a Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, United States b Division of Cardiology, Mayo Clinic, Rochester, MN 55905, United States c Sphingotec GmbH, Hennigsdorf, Germany ARTICLE INFO ABSTRACT Keywords: Background: Endogenous opioids, enkephalins, are known to increase with acute kidney injury. Since the mature Biomarkers pentapeptides are unstable, we evaluated the performance of an assay that measures proenkephalin 119–159 Proenkephalin (PENK), a stable peptide formed concomitantly with mature enkephalins. Enkephalin Methods: PENK assay performance was evaluated on two microtiterplate/chemiluminescence sandwich im- Pro-enkephalin munoassay formats that required 18 or 1 h incubation times. PENK concentration was measured in plasma from penKid healthy individuals to establish a reference interval and in patients with varied levels of kidney function and Assay validation comorbidities to assess the association with measured glomerular filtration rate (mGFR) using iothalamate clearance. Results: Assay performance characteristics in plasma were similar between the assay formats. Limit of quanti- tation was 26.0 pmol/L (CV = 20%) for the 1 h assay and 17.3 pmol/L (CV = 3%) for the 18 h assay. Measurable ranges were 26–1540 pmol/L (1 h assay) and 18–2300 pmol/L (18 h assay). PENK concentrations are stable in plasma stored ambient to 10 days, refrigerated to at least 15 days, and frozen to at least 90 days.
    [Show full text]
  • Sigma Fatty Acids, Glycerides, Oils and Waxes
    Sigma Fatty Acids, Glycerides, Oils and Waxes Library Listing – 766 spectra This library represents a material-specific subset of the larger Sigma Biochemical Condensed Phase Library relating to relating to fatty acids, glycerides, oils, and waxes found in the Sigma Biochemicals and Reagents catalog. Spectra acquired by Sigma-Aldrich Co. which were examined and processed at Thermo Fisher Scientific. The spectra include compound name, molecular formula, CAS (Chemical Abstract Service) registry number, and Sigma catalog number. Sigma Fatty Acids, Glycerides, Oils and Waxes Index Compound Name Index Compound Name 464 (E)-11-Tetradecenyl acetate 592 1-Monocapryloyl-rac-glycerol 118 (E)-2-Dodecenedioic acid 593 1-Monodecanoyl-rac-glycerol 99 (E)-5-Decenyl acetate 597 1-Monolauroyl-rac-glycerol 115 (E)-7,(Z)-9-Dodecadienyl acetate 599 1-Monolinolenoyl-rac-glycerol 116 (E)-8,(E)-10-Dodecadienyl acetate 600 1-Monolinoleoyl-rac-glycerol 4 (E)-Aconitic acid 601 1-Monomyristoyl-rac-glycerol 495 (E)-Vaccenic acid 598 1-Monooleoyl-rac-glycerol 497 (E)-Vaccenic acid methyl ester 602 1-Monopalmitoleoyl-rac-glycerol 98 (R)-(+)-2-Chloropropionic acid methyl 603 1-Monopalmitoyl-rac-glycerol ester 604 1-Monostearoyl-rac-glycerol; 1- 139 (Z)-11-Eicosenoic anhydride Glyceryl monosterate 180 (Z)-11-Hexadecenyl acetate 589 1-O-Hexadecyl-2,3-dipalmitoyl-rac- 463 (Z)-11-Tetradecenyl acetate glycerol 181 (Z)-3-Hexenyl acetate 588 1-O-Hexadecyl-rac-glycerol 350 (Z)-3-Nonenyl acetate 590 1-O-Hexadecyl-rac-glycerol 100 (Z)-5-Decenyl acetate 591 1-O-Hexadecyl-sn-glycerol
    [Show full text]
  • Activation of 5-HT2C (But Not 5-HT1A) Receptors in the Amygdala Enhances Fear-Induced Antinociception: Blockade with Local 5-HT2C Antagonist Or Systemic fluoxetine
    Neuropharmacology 135 (2018) 376e385 Contents lists available at ScienceDirect Neuropharmacology journal homepage: www.elsevier.com/locate/neuropharm Activation of 5-HT2C (but not 5-HT1A) receptors in the amygdala enhances fear-induced antinociception: Blockade with local 5-HT2C antagonist or systemic fluoxetine Lígia Renata Rodrigues Tavares a, b, Daniela Baptista-de-Souza a, c, * Azair Canto-de-Souza a, b, c, d, a Psychobiology Group, Department of Psychology/CECH- Federal University of Sao~ Carlos-UFSCar, Sao~ Carlos, Sao~ Paulo, 13565-905, Brazil b Joint Graduate Program in Physiological Sciences UFSCar/UNESP, Sao~ Carlos, Sao~ Paulo, 13565-905, Brazil c Neuroscience and Behavioral Institute-IneC, Ribeirao~ Preto, Sao~ Paulo, 14040-901, Brazil d Program in Psychology UFSCar, Sao~ Carlos, Sao~ Paulo, 13565-905, Brazil article info abstract Article history: It is well-known that the exposure of rodents to threatening environments [e.g., the open arm of the Received 17 August 2017 elevated-plus maze (EPM)] elicits pain inhibition. Systemic and/or intracerebral [e.g., periaqueductal gray Received in revised form matter, amygdala) injections of antiaversive drugs [e.g., serotonin (5-HT) ligands, selective serotonin 5 March 2018 reuptake inhibitors (SSRIs)] have been used to change EPM-open arm confinement induced anti- Accepted 6 March 2018 nociception (OAA). Here, we investigated (i) the role of the 5-HT and 5-HT receptors located in the Available online 13 March 2018 1A 2C amygdaloid complex on OAA as well as (ii) the effects of systemic pretreatment with fluoxetine (an SSRI) on the effects of intra-amygdala injections of 8-OH-DPAT (a 5-HT1A agonist) or MK-212 (a 5-HT2C agonist) Keywords: fi Amygdala on nociception in mice con ned to the open arm or enclosed arm of the EPM.
    [Show full text]
  • Synthesis of Optically Pure Macroheterocycles with 2,6-Pyridinedicarboxylic and Adipic Acid Fragments from ∆3-Carene
    Macrolides Paper Макролиды Статья DOI: 10.6060/mhc190660y Synthesis of Optically Pure Macroheterocycles with 2,6-Pyridinedicarboxylic and Adipic Acid Fragments from ∆3-Carene Marina P. Yakovleva,@ Kseniya S. Denisova, Galina R. Mingaleeva, Valentina A. Vydrina, and Gumer Yu. Ishmuratov Ufa Institute of Chemistry, Ufa Federal Research Center, Russian Academy of Sciences, 450054 Ufa, Russia @Corresponding author E-mail: [email protected] Based on the available natural monoterpene ∆3-carene we have developed the synthesis of four optically pure macroheterocycles with ester and dihydrazide fragments through the intermediate 1-((1S,3R)-3-(2-hydroxyethyl- 2,2-dimethylcyclopropyl)propan-2-one using its [2+1]-interaction with dichloranhydrides of adipic or 2,6-pyridinedicarboxylic acids and [1+1]-condensation of the obtained α,ω-diketodiesters with dihydrazides of adipic or 2,6-pyridinedicarboxylic acids. The structure of new compounds was confirmed by IR and NMR spectroscopy and mass spectrometry. Keywords: 3-Carenes, ozonolysis, sodium hypochlorite, macroheterocycles with ester and dihydrazide fragments, [2+1] and [1+1] condensations, synthesis. Синтез оптически чистых макрогетероциклов со сложноэфирными и дигидразидными фрагментами адипиновой и 2,6-пиридиндикарбоновой кислот из D3-карена М. П. Яковлева,@ К. С. Денисова, Г. Р. Мингалеева, В. А. Выдрина, Г. Ю. Ишмуратов Уфимский Институт химии – обособленное структурное подразделение Федерального бюджетного научного учреждения Уфимского федерального исследовательского центра Российской академии
    [Show full text]
  • Antitumor Activity of Actinonin in Vitro and in Vivo
    Vol. 4, 171-176, January 1998 Clinical Cancer Research 171 Antitumor Activity of Actinonin in Vitro and in Vivo Yang Xu, Lawrence T. Lai, Janice L. Gabrilove, 8), mye!oid and monocytic cells, and most myeloblastic leuke- and David A. Scheinberg’ mias as well as on cells and tissues outside the hematopoietic system including fibroblasts, intestinal epithelium, renal tubular Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 epithelium, and synaptic membranes of the central nervous system (I ). APN occurs as a homodimer, and the molecule is a 150-kDa, transmembrane glycoprotein with an intracellular ABSTRACT amino terminus (1). F23, an antihuman CD13/APN mAb, is able Actinonin, an antibiotic and CD13/aminopeptidase N to completely block the active site of the enzyme (9). (APN) inhibitor, has been shown to be cytotoxic to tumor Bestatin, a CD 1 3/APN inhibitor, was examined in preclin- cell lines in vitro. We investigated the antiproliferative ef- ical and clinical studies; bestatin could inhibit lymph node fects of actinonin on human and murine leukemia and lym- metastasis of P388 leukemia in mice (10) and was used in phoma cells. Actinonin inhibited growth of NB4 and HL6O clinical trials in malignant skin tumors (1 1), in head and neck human cell lines and AKR mouse leukemia cells in vitro with cancer (12), in esophageal cancer (13), and in gynecologic an IC50 of about 2-S g/ml. The inhibitory effect on CD13- tumors (14). High doses of bestatin resulted in the significant positive cells was not blocked by pretreatment with the inhibition of preexisting experimental and spontaneous metas- anti-CD13/APN monoclonal antibody F23, which binds with tasis in mice (15).
    [Show full text]
  • SCOMET List 2013
    (Annexure to Notification No. 37(RE-2012)/2009-2014 Dated 14.03.2013) Special Chemicals, Organisms, Materials, Equipment and Technologies (SCOMET) export of which is regulated Export of Special Chemicals, Organisms, Materials, Equipment and Technologies (SCOMET) listed below shall be permitted only against an export licence issued in this behalf unless export is prohibited or is permitted without licence subject to fulfillment of conditions, if any, as indicated under/against any specific category or item. Provisions of Chapter IV A of the FT(D&R) Act,1992 as amended in 2010 shall apply to the goods, services and technologies specified in the list below. Supply of SCOMET Items from DTA to SEZ No export permission is required for supply of SCOMET items from DTA to SEZ. However, all supplies of SCOMET items from DTA to SEZ will be reported to the Development Commissioner of the respective SEZ by the supplier in the prescribed proforma (Annexure 1) within one (1) week of the supplies getting effected. An annual report of such supplies from DTA to SEZ shall be sent to SCOMET Cell, DGFT (Hqrs), Department of Commerce, Udyog Bhawan, Maulana Azad Road, New Delhi-110011, by the Development Commissioner (DC), SEZ in the prescribed proforma (Annexure 2) . Report by the DC, SEZ to be filed by 15th May of every financial year for the supplies effected during the preceding financial year. Export of SCOMET Items from SEZ to outside the country Export permission is required if the SCOMET items are to be physically exported outside the country from SEZ i.e.
    [Show full text]
  • Synthesis and Characterization of Hydrophobically Modified Derivatives of Polysaccharides Xia Miao
    Synthesis and characterization of hydrophobically modified derivatives of polysaccharides Xia Miao To cite this version: Xia Miao. Synthesis and characterization of hydrophobically modified derivatives of polysaccha- rides. Other [q-bio.OT]. Université de Grenoble; Sichuan University, 2011. English. NNT : 2011GRENV054. tel-00666983 HAL Id: tel-00666983 https://tel.archives-ouvertes.fr/tel-00666983 Submitted on 6 Feb 2012 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE Pour obtenir le grade de DOCTEUR DE L’UNIVERSITÉ DE GRENOBLE Spécialité : Sciences des polymères Arrêté ministériel : 7 août 2006 Présentée par Xia MIAO Thèse dirigée par Rachel Auzély-Velty et Bo JIANG préparée au sein du Centre de Recherches sur les Macromolécules Végétales (CERMAV-CNRS) dans l'École Doctorale de Chimie et Science Vivante Hydrophobically modified derivatives of polysaccharides Thèse soutenue publiquement le 4 Octobre 2011, devant le jury composé de : M. Saïd SADKI Professeur, Université Joseph Fourier, Grenoble, Examinateur M. Christophe Chassenieux Professeur, Université du Maine, Le Mans, Rapporteur M. Yujun Feng Professeur, Chengdu Institute of Organic Chemistry – CAS, Rapporteur M. Ming Xiang Professeur, PRI & SKLPMEC, Sichuan University, Examinateur M. Bo JIANG Professeur, College of Chemistry, Sichuan University, Directeur de thèse Mme.
    [Show full text]
  • Beverage Preparation Capsule for Delivery of a Solubilisate
    (19) TZZ¥ _¥_T (11) EP 3 216 443 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 13.09.2017 Bulletin 2017/37 A61K 9/00 (2006.01) A47J 31/40 (2006.01) A47J 31/00 (2006.01) B65D 85/804 (2006.01) (21) Application number: 16000586.4 (22) Date of filing: 10.03.2016 (84) Designated Contracting States: (71) Applicant: Athenion AG AL AT BE BG CH CY CZ DE DK EE ES FI FR GB 6304 Zug (CH) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (72) Inventors: Designated Extension States: • Brysch, Ekkehard BA ME 26316 Varel (DE) Designated Validation States: • Brysch, Wolfgang MA MD 13505 Berlin (DE) • von Wegerer, Jörg 13597 Berlin (DE) (54) BEVERAGE PREPARATION CAPSULE FOR DELIVERY OF A SOLUBILISATE (57) The present invention relates to a beverage pensing system. Poorly water-soluble dietary supple- preparation capsule for the delivery of a solubilisate, a ments or pharmaceutical active agents can be delivered beverage dispensing system configured for the use of in this new dosage form in order to increase the bioavail- such a beverage preparation capsule and a method for ability of these substances. preparing a beverage by means of such a beverage dis- EP 3 216 443 A1 Printed by Jouve, 75001 PARIS (FR) 1 EP 3 216 443 A1 2 Description bilayer of the cell membrane. Often the same or struc- turally related components are used for liposomes as [0001] The present invention relates to a beverage those known from the cell membrane, therefore display- preparation capsule for the delivery of a solubilisate, a ing similar physicochemical properties.
    [Show full text]
  • Drug and Medication Classification Schedule
    KENTUCKY HORSE RACING COMMISSION UNIFORM DRUG, MEDICATION, AND SUBSTANCE CLASSIFICATION SCHEDULE KHRC 8-020-1 (11/2018) Class A drugs, medications, and substances are those (1) that have the highest potential to influence performance in the equine athlete, regardless of their approval by the United States Food and Drug Administration, or (2) that lack approval by the United States Food and Drug Administration but have pharmacologic effects similar to certain Class B drugs, medications, or substances that are approved by the United States Food and Drug Administration. Acecarbromal Bolasterone Cimaterol Divalproex Fluanisone Acetophenazine Boldione Citalopram Dixyrazine Fludiazepam Adinazolam Brimondine Cllibucaine Donepezil Flunitrazepam Alcuronium Bromazepam Clobazam Dopamine Fluopromazine Alfentanil Bromfenac Clocapramine Doxacurium Fluoresone Almotriptan Bromisovalum Clomethiazole Doxapram Fluoxetine Alphaprodine Bromocriptine Clomipramine Doxazosin Flupenthixol Alpidem Bromperidol Clonazepam Doxefazepam Flupirtine Alprazolam Brotizolam Clorazepate Doxepin Flurazepam Alprenolol Bufexamac Clormecaine Droperidol Fluspirilene Althesin Bupivacaine Clostebol Duloxetine Flutoprazepam Aminorex Buprenorphine Clothiapine Eletriptan Fluvoxamine Amisulpride Buspirone Clotiazepam Enalapril Formebolone Amitriptyline Bupropion Cloxazolam Enciprazine Fosinopril Amobarbital Butabartital Clozapine Endorphins Furzabol Amoxapine Butacaine Cobratoxin Enkephalins Galantamine Amperozide Butalbital Cocaine Ephedrine Gallamine Amphetamine Butanilicaine Codeine
    [Show full text]